Delivery Order SPE2DB22D2007-SPE2DB25FJ5EC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,448.35 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside contract was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $19,727.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 4, 2025. This non-competitive delivery order, issued on September 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The pharmaceutical product will be delivered...
- The Defense Logistics Agency awarded a delivery order valued at $10,786.08 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector medication. This non-set-aside, firm fixed-price delivery order was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $9,735.80 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is firm fixed price with no set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $11,793.61 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. The contract, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,692.59 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $18,462.83 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $9,811.24 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on September 9, 2025, with completion targeted for September 10, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $9,833.30 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors on August 25, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by August...
- The Defense Logistics Agency awarded a $11,283.59 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick autoinjectors on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed price, competitively awarded contract (no set-aside used) is for delivery to the company's headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5ECDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,306.22 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded contract was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Repatha is a prescription medication used to treat high cholesterol and reduce cardiovascular risk in eligible patient populations. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen fulfills federal medical supply needs through both the DLA's Medical Supply Chain and the broader Pharmaceutical Prime Vendor program, which serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award reflects AmerisourceBergen's established capability to meet federal procurement requirements through open competition and its extensive portfolio of brand-name and specialty pharmaceutical products supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.3k | 9/19/25 |